MedTrace Logo

Rheumatic Heart Disease Study in Lusaka

NCT02661763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1024

Last updated 2016-11-08

No results posted yet for this study

Summary

This study will determine the prevalence of rheumatic heart disease (RHD) in Lusaka, Zambia through school-based screening methodology using ultraportable echocardiography and a recently validated, abridged screening protocol based on World Heart Federation criteria. Children that screen positive for RHD at schools will undergo confirmatory evaluation at University Teaching Hospital (UTH), Lusaka's main referral hospital.

Conditions

  • Rheumatic Heart Disease

Sponsors & Collaborators

  • University of Cape Town

    collaborator OTHER

  • Novartis

    collaborator INDUSTRY

  • University of Zambia

    lead OTHER

Principal Investigators

  • John Musuku, Doctor · University of Zambia / University Teaching Hospital

Eligibility

Min Age
10 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02661763 on ClinicalTrials.gov